Healthcare Focus Fulcrum Research Group specializes in primary market research for the healthcare sector, presenting a clear opportunity to upsell tailored quantitative and qualitative studies to pharma, biotech, and medical device clients seeking market dynamics, competitive edge, and product positioning insights.

Acquisition Momentum As part of SAI MedPartners, Fulcrum sits within a growing family of analytics and CI capabilities, suggesting a natural cross-sell path for integrated services such as competitive intelligence, market landscape analyses, and path-to-market strategy support for existing and prospective clients.

Tech Enablement Utilizing OpenAI and a Microsoft-powered stack (365, Dynamics, Azure, Intune, Active Directory) indicates a tech-forward approach; leverage for offering AI-assisted research design, faster data insights, and secure collaboration to attract tech-savvy healthcare brands and streamlined engagement.

Mid-market Focus With 51-200 employees and revenue in the $10M–$25M range, target mid-market pharmaceutical and device companies seeking nimble, customized research partnerships; position Fulcrum as a flexible, tangible value driver for rapid decision-making.

Growth Catalyst Recent and ongoing M&A activity within SAI MedPartners, including acquisitions of The Dunn Group and IDEA Pharma, signals a growth narrative and expanded service horizons; offer bundled research solutions that align with the broader strategic ambitions of clients undergoing integration or expansion.